Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer

Background and objectiveWhether sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) for breast cancer is an alternative to axillary lymph node dissection (ALND) remains controversial. In this study, the results of SLNB performed with 99mTc-Rituximab combined with dyes were analyze...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Minxue Zhuang, Yidan Lin, HongBin Qiu, Wei Chen, Ruo Wang, HuanHong Zeng, Mengbo Lin, Hui Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Subjects:	breast cancer neoadjuvant chemotherapy (NAC) sentinel lymph node biopsy (SLNB) 99mTc-Rituximab axillary lymph node dissection (ALND)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1568550/full